Document Detail


Effects of chromium picolinate on food intake and satiety.
MedLine Citation:
PMID:  18715218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Chromium picolinate (CrPic) has been shown to attenuate weight gain, but the mechanism underlying this effect is unknown.
METHODS: We assessed the effect of CrPic in modulating food intake in healthy, overweight, adult women who reported craving carbohydrates (Study 1) and performed confirmatory studies in Sprague-Dawley rats (Study 2). Study 1 utilized a double-blind placebo-controlled design and randomly assigned 42 overweight adult women with carbohydrate cravings to receive 1,000 mg of CrPic or placebo for 8 weeks. Food intake at breakfast, lunch, and dinner was directly measured at baseline, week 1, and week 8. For Study 2, Sprague-Dawley rats were fasted for 24 h and subsequently injected intraperitoneally with 0, 1, 10, or 50 microg/kg CrPic. Subsequently, rats were implanted with an indwelling third ventricular cannula. Following recovery, 0, 0.4, 4, or 40 ng of CrPic was injected directly into the brain via the intracerebroventricular cannula, and spontaneous 24-h food intake was measured.
RESULTS: Study 1 demonstrated that CrPic, as compared to placebo, reduced food intake (P<0.0001), hunger levels (P<0.05), and fat cravings (P<0.0001) and tended to decrease body weight (P=0.08). In study 2, intraperitoneal administration resulted in a subtle decrease in food intake at only the highest dose (P=0.03). However, when administered centrally, CrPic dose-dependently decreased food intake (P<0.05).
CONCLUSIONS: These data suggest CrPic has a role in food intake regulation, which may be mediated by a direct effect on the brain.
Authors:
Stephen D Anton; Christopher D Morrison; William T Cefalu; Corby K Martin; Sandra Coulon; Paula Geiselman; Hongmei Han; Christy L White; Donald A Williamson
Related Documents :
8778838 - Effect of the noncompetitive n-methyl-d-aspartate (nmda) receptor antagonist mk-801 on ...
18082228 - Central blockade of melanocortin receptors attenuates the metabolic and locomotor respo...
18715218 - Effects of chromium picolinate on food intake and satiety.
11240008 - Relationships between feeding and locomotion behaviors after central administration of ...
7441088 - The total alkaloid and anagyrine contents of some bitter and sweet selections of lupin ...
3270518 - Pesticide residue control in the years 1980-1982.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  10     ISSN:  1520-9156     ISO Abbreviation:  Diabetes Technol. Ther.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-08-21     Completed Date:  2008-10-15     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  405-12     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Blood Glucose / metabolism
Dose-Response Relationship, Drug
Double-Blind Method
Eating / drug effects*
Female
Humans
Insulin / blood
Iron Chelating Agents / adverse effects,  pharmacology*
Male
Middle Aged
Pain Measurement
Picolinic Acids / adverse effects,  pharmacology*
Rats
Rats, Sprague-Dawley
Satiety Response / drug effects*
Grant Support
ID/Acronym/Agency:
P30 DK072476/DK/NIDDK NIH HHS; P30 DK072476-04/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Insulin; 0/Iron Chelating Agents; 0/Picolinic Acids; QZV2W997JQ/picolinic acid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type...
Next Document:  Proteomic identification of the silkworm (Bombyx mori L) prothoracic glands during the fifth instar ...